全球血液和血液成分市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測

全球血液和血液成分市場需求預計將從 2023 年的 179.6 億美元達到近 254 億美元的市場規模，2024-2032 年研究期間複合年成長率為 3.93%。

血液和血液成分是指用於醫療治療的全血及其分離成分，例如紅血球、白血球、血小板和血漿。這些成分對於各種治療目的至關重要，包括貧血、凝血障礙、創傷和外科手術患者的輸血。血液成分與接受者的血型仔細匹配，以確保相容性和安全性。將血液分離成其成分可以進行有針對性的治療，最佳化捐捐血液的使用並改善各種臨床環境中的患者治療效果。

市場動態

創傷病例、外科手術和慢性疾病的發生率不斷上升，需要使用血液和血液成分來有效管理患者的病情。此外，全球人口老化，更容易受到需要輸血的醫療狀況的影響，顯著提振了市場。血液採集、處理和儲存技術的進步正在提高血液和血液成分的安全性和效率，進一步推動其需求。人們對捐血的認知不斷提高以及政府鼓勵自願捐血的舉措也是推動市場的重要因素。此外，開發先進的篩檢和測試方法以確保血液和血液成分的安全也有助於市場成長。全球醫院、血庫和醫療機構數量的增加正在擴大這些關鍵產品的可用性和可近性。然而，輸血傳播感染的風險以及血液處理和儲存的高成本可能會挑戰未來幾年的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球血液和血液成分市場的每個細分市場進行了包容性評估。血液和血液成分產業的成長和趨勢為本研究提供了整體方法。

市場區隔

血液和血液成分市場報告的這一部分提供了有關國家和區域級別細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按產品分類

• 全血
• 血液成分（紅血球、血小板、血漿、白血球）

按申請

• 貧血
• 創傷與手術
• 癌症治療
• 出血性疾病
• 其他

按最終用途

• 醫院
• 門診手術中心
• 其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲的血液和血液成分市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。血液和血液成分市場的主要參與者包括歐洲血液聯盟、澳洲紅十字會、印度紅十字會、美國血庫協會、南非國家血液服務中心。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第1章：前言

• 報告說明
  • 客觀的
  • 目標受眾
  • 獨特的銷售主張 (USP) 和產品
• 研究範圍
• 研究方法論
  • 市場研究過程
  • 市場研究方法論

第 2 章：執行摘要

• 市場亮點
• 全球市場概況

第 3 章：血液和血液成分 - 產業分析

• 簡介 - 市場動態
• 市場促進因素
• 市場限制
• 機會
• 產業動態
• 波特五力分析
• 市場吸引力分析
  • 按產品分類的市場吸引力分析
  • 市場吸引力分析：依應用分類
  • 按最終用途分類的市場吸引力分析
  • 市場吸引力分析：按地區

第 4 章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料廠商清單
  • 主要原物料價格走勢
• 潛在買家名單
• 行銷管道
  • 直效行銷
  • 間接行銷
  • 行銷通路發展趨勢

第 5 章：全球血液和血液成分市場分析：按產品分類

• 概述（按產品）
• 按產品分類的歷史和預測資料分析
• 全血
• 血液成分（紅血球、血小板、血漿、白血球）

第 6 章：全球血液與血液成分市場分析：按應用分類

• 概述：按應用
• 歷史和預測數據分析：按應用
• 貧血
• 創傷與手術
• 癌症治療
• 出血性疾病
• 其他

第 7 章：全球血液與血液成分市場分析：依最終用途分類

• 按最終用途分類的概述
• 按最終用途進行歷史和預測資料分析
• 醫院
• 門診手術中心
• 其他

第 8 章：全球血液和血液成分市場分析：按地理位置

• 區域展望
• 介紹
• 北美銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 北美按細分市場銷售分析
  • 北美按國家銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 歐洲按細分市場銷售分析
  • 歐洲按國家銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 亞太地區按細分市場銷售分析
  • 亞太地區按國家銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳洲銷售分析
  • 東南亞銷售分析
  • 亞太地區其他地區銷售分析
• 拉丁美洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 拉丁美洲按細分市場銷售分析
  • 拉丁美洲按國家銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 中東和非洲按細分市場銷售分析
  • 中東和非洲按國家銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東其他地區和非洲銷售分析

第 9 章：血液與血液成分公司的競爭格局

• 血液和血液成分市場競爭
• 夥伴關係/協作/協議
• 併購
• 新產品發布
• 其他發展

第 10 章：公司簡介

• 頂級公司市佔率分析
• 市場集中度
• European Blood Alliance
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Australian Red Cross
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Indian Red Cross
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• American Association Of Blood Banks
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• South African National Blood Service
• 公司簡介
• 公司收入
• 產品
• 最近的發展

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

The global demand for Blood and Blood Components Market is presumed to reach the market size of nearly USD 25.4 Billion by 2032 from USD 17.96 Billion in 2023 with a CAGR of 3.93% under the study period 2024-2032.

Blood and blood components refer to whole blood and its separated components, such as red blood cells, white blood cells, platelets, and plasma, used in medical treatments. These components are critical for various therapeutic purposes, including transfusions for patients with anemia, clotting disorders, trauma, and surgical procedures. Blood components are carefully matched to the recipient's blood type to ensure compatibility and safety. The separation of blood into its components allows for targeted treatments, optimizing the use of donated blood and improving patient outcomes in various clinical settings.

MARKET DYNAMICS

The rising incidence of trauma cases, surgical procedures, and chronic diseases necessitates the use of blood and blood components to manage patients' conditions effectively. Additionally, the aging global population, more susceptible to medical conditions requiring blood transfusions, significantly boosts the market. Advancements in blood collection, processing, and storage technologies are enhancing the safety and efficiency of blood and blood components, further driving their demand. The increasing awareness about blood donation and government initiatives to encourage voluntary blood donation are also significant factors propelling the market. Furthermore, the development of advanced screening and testing methods to ensure the safety of blood and blood components contributes to market growth. The rise in the number of hospitals, blood banks, and healthcare facilities globally is expanding the availability and accessibility of these critical products. However, the risk of transfusion-transmitted infections and the high cost of blood processing and storage may challenge market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Blood and Blood Components. The growth and trends of Blood and Blood Components industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Blood and Blood Components market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Whole Blood
• Blood Components (Red blood cells, Platelets, Plasma, White Blood Cells)

By Application

• Anaemia
• Trauma & Surgery
• Cancer Treatment
• Bleeding Disorders
• Others

By End-Use

• Hospitals
• Ambulatory Surgical Centers
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Blood and Blood Components market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Blood and Blood Components market include European Blood Alliance, Australian Red Cross, Indian Red Cross, American Association Of Blood Banks, South African National Blood Service. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. BLOOD AND BLOOD COMPONENTS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-Use
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL BLOOD AND BLOOD COMPONENTS MARKET ANALYSIS BY PRODUCT

• 5.1. Overview By Product
• 5.2. Historical and Forecast Data Analysis By Product
• 5.3. Whole Blood Historic and Forecast Sales By Regions
• 5.4. Blood Components (Red blood cells, Platelets, Plasma, White Blood Cells) Historic and Forecast Sales By Regions

6. GLOBAL BLOOD AND BLOOD COMPONENTS MARKET ANALYSIS BY APPLICATION

• 6.1. Overview By Application
• 6.2. Historical and Forecast Data Analysis By Application
• 6.3. Anaemia Historic and Forecast Sales By Regions
• 6.4. Trauma & Surgery Historic and Forecast Sales By Regions
• 6.5. Cancer Treatment Historic and Forecast Sales By Regions
• 6.6. Bleeding Disorders Historic and Forecast Sales By Regions
• 6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL BLOOD AND BLOOD COMPONENTS MARKET ANALYSIS BY END-USE

• 7.1. Overview By End-Use
• 7.2. Historical and Forecast Data Analysis By End-Use
• 7.3. Hospitals Historic and Forecast Sales By Regions
• 7.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
• 7.5. Others Historic and Forecast Sales By Regions

8. GLOBAL BLOOD AND BLOOD COMPONENTS MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE BLOOD AND BLOOD COMPONENTS COMPANIES

• 9.1. Blood and Blood Components Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF BLOOD AND BLOOD COMPONENTS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. European Blood Alliance
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. Australian Red Cross
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Indian Red Cross
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. American Association Of Blood Banks
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. South African National Blood Service
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers: Impact Analysis
• Restraints: Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• Analysis By Product (USD MN)
• Whole Blood Market Sales By Geography (USD MN)
• Blood Components (Red blood cells, Platelets, Plasma, White Blood Cells) Market Sales By Geography (USD MN)
• Analysis By Application (USD MN)
• Anaemia Market Sales By Geography (USD MN)
• Trauma & Surgery Market Sales By Geography (USD MN)
• Cancer Treatment Market Sales By Geography (USD MN)
• Bleeding Disorders Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Analysis By End-Use (USD MN)
• Hospitals Market Sales By Geography (USD MN)
• Ambulatory Surgical Centers Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Blood and Blood Components Market Sales By Geography (USD MN)
• North America Market Analysis (USD MN)
• United States Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate By Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Blood and Blood Components Report
• Market Research Process
• Market Research Methodology
• Global Blood and Blood Components Market Size, By Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis By Product
• Market Attractiveness Analysis By Application
• Market Attractiveness Analysis By End-Use
• Market Attractiveness Analysis By Region
• Value Chain Analysis
• Global Market Analysis By Product (USD MN)
• Whole Blood Market Sales By Geography (USD MN)
• Blood Components (Red blood cells, Platelets, Plasma, White Blood Cells) Market Sales By Geography (USD MN)
• Global Market Analysis By Application (USD MN)
• Anaemia Market Sales By Geography (USD MN)
• Trauma & Surgery Market Sales By Geography (USD MN)
• Cancer Treatment Market Sales By Geography (USD MN)
• Bleeding Disorders Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Market Analysis By End-Use (USD MN)
• Hospitals Market Sales By Geography (USD MN)
• Ambulatory Surgical Centers Market Sales By Geography (USD MN)
• Others Market Sales By Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.